Sex Differences in Efficacy and Toxicity of Systemic Treatments: An Undervalued Issue in the Era of Precision Oncology

J Clin Oncol. 2018 Sep 10;36(26):2680-2683. doi: 10.1200/JCO.2018.78.3290. Epub 2018 Jul 13.
No abstract available

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Female
  • Humans
  • Male
  • Medical Oncology
  • Precision Medicine*
  • Sex Characteristics*

Substances

  • Antineoplastic Agents